The content on this site is intended for healthcare professionals only
Dr Etienne De Braekeleer presents results at the 2019 European Hematology Association (EHA) Annual Meeting from a study looking at the mutations in NOTCH1 that drive T-ALL cells to multiply rapidly.
A CRISPR-Cas9-based method was used to screen the human genome and highlight potential targetable genes.
Inhibiting one of these genes, NADK, was shown to greatly inhibit T-ALL cells from growing.
Insights into germline genetic screening of breast cancer patients
New classification for identifying HR myeloma based on cytogenetic abnormalities
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
Ide-cel significantly prolongs PFS for r/r multiple myeloma versus standard regimens
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
